S190: ASXL1 MUTATIONS ACCELERATE BONE MARROW FIBROSIS VIA EGR1-TNFA AXIS MEDIATED INFLAMMATION AND FIBROCYTE GENERATION IN MYELOPROLIFERATIVE NEOPLASMS
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843652.05474.21 |
| _version_ | 1797281772878168064 |
|---|---|
| author | Z. Shi J. Liu Y. Zhao L. Yang Y. Cai P. Zhang Z. Xu T. Qin S. Qu L. Pan J. Wu X. Yan Z. Li W. Zhang Y. Yan H. Huang G. Huang B. Li X. Wu Z. Xiao |
| author_facet | Z. Shi J. Liu Y. Zhao L. Yang Y. Cai P. Zhang Z. Xu T. Qin S. Qu L. Pan J. Wu X. Yan Z. Li W. Zhang Y. Yan H. Huang G. Huang B. Li X. Wu Z. Xiao |
| author_sort | Z. Shi |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:02:16Z |
| format | Article |
| id | doaj.art-c57b97b19ce4458dabddb568d559b6a3 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:02:16Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-c57b97b19ce4458dabddb568d559b6a32024-03-03T03:19:20ZengWileyHemaSphere2572-92412022-06-016919210.1097/01.HS9.0000843652.05474.21202206003-00091S190: ASXL1 MUTATIONS ACCELERATE BONE MARROW FIBROSIS VIA EGR1-TNFA AXIS MEDIATED INFLAMMATION AND FIBROCYTE GENERATION IN MYELOPROLIFERATIVE NEOPLASMSZ. Shi0J. Liu1Y. Zhao2L. Yang3Y. Cai4P. Zhang5Z. Xu6T. Qin7S. Qu8L. Pan9J. Wu10X. Yan11Z. Li12W. Zhang13Y. Yan14H. Huang15G. Huang16B. Li17X. Wu18Z. Xiao191 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin3 Department of Cell Biology, Tianjin Medical University1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin4 pathology center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin, China1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin3 Department of Cell Biology, Tianjin Medical University1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin5 Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America6 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College7 Department of Cell Biology, Tianjin Medical University1 MDS/MPN center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjinhttp://journals.lww.com/10.1097/01.HS9.0000843652.05474.21 |
| spellingShingle | Z. Shi J. Liu Y. Zhao L. Yang Y. Cai P. Zhang Z. Xu T. Qin S. Qu L. Pan J. Wu X. Yan Z. Li W. Zhang Y. Yan H. Huang G. Huang B. Li X. Wu Z. Xiao S190: ASXL1 MUTATIONS ACCELERATE BONE MARROW FIBROSIS VIA EGR1-TNFA AXIS MEDIATED INFLAMMATION AND FIBROCYTE GENERATION IN MYELOPROLIFERATIVE NEOPLASMS HemaSphere |
| title | S190: ASXL1 MUTATIONS ACCELERATE BONE MARROW FIBROSIS VIA EGR1-TNFA AXIS MEDIATED INFLAMMATION AND FIBROCYTE GENERATION IN MYELOPROLIFERATIVE NEOPLASMS |
| title_full | S190: ASXL1 MUTATIONS ACCELERATE BONE MARROW FIBROSIS VIA EGR1-TNFA AXIS MEDIATED INFLAMMATION AND FIBROCYTE GENERATION IN MYELOPROLIFERATIVE NEOPLASMS |
| title_fullStr | S190: ASXL1 MUTATIONS ACCELERATE BONE MARROW FIBROSIS VIA EGR1-TNFA AXIS MEDIATED INFLAMMATION AND FIBROCYTE GENERATION IN MYELOPROLIFERATIVE NEOPLASMS |
| title_full_unstemmed | S190: ASXL1 MUTATIONS ACCELERATE BONE MARROW FIBROSIS VIA EGR1-TNFA AXIS MEDIATED INFLAMMATION AND FIBROCYTE GENERATION IN MYELOPROLIFERATIVE NEOPLASMS |
| title_short | S190: ASXL1 MUTATIONS ACCELERATE BONE MARROW FIBROSIS VIA EGR1-TNFA AXIS MEDIATED INFLAMMATION AND FIBROCYTE GENERATION IN MYELOPROLIFERATIVE NEOPLASMS |
| title_sort | s190 asxl1 mutations accelerate bone marrow fibrosis via egr1 tnfa axis mediated inflammation and fibrocyte generation in myeloproliferative neoplasms |
| url | http://journals.lww.com/10.1097/01.HS9.0000843652.05474.21 |
| work_keys_str_mv | AT zshi s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT jliu s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT yzhao s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT lyang s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT ycai s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT pzhang s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT zxu s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT tqin s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT squ s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT lpan s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT jwu s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT xyan s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT zli s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT wzhang s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT yyan s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT hhuang s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT ghuang s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT bli s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT xwu s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms AT zxiao s190asxl1mutationsacceleratebonemarrowfibrosisviaegr1tnfaaxismediatedinflammationandfibrocytegenerationinmyeloproliferativeneoplasms |